BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27617475)

  • 21. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
    Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
    J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The classification of lung carcinoma: time to change the morphology-based approach?
    Pelosi G; Sonzogni A; Viale G
    Int J Surg Pathol; 2010 Jun; 18(3):161-72. PubMed ID: 20460313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S; Verdun T; Churg A
    Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
    Russell PA; Rogers TM; Solomon B; Alam N; Barnett SA; Rathi V; Williams RA; Wright GM; Conron M
    Pathology; 2017 Oct; 49(6):604-610. PubMed ID: 28811082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
    Yvorel V; Patoir A; Casteillo F; Tissot C; Fournel P; Stachowicz ML; Karpathiou G; Tiffet O; Péoc'h M; Forest F
    PLoS One; 2017; 12(7):e0180346. PubMed ID: 28671973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Large cell carcinoma, lymphoepithelioma-like carcinoma, NUT carcinoma].
    Copin MC
    Ann Pathol; 2016 Jan; 36(1):24-33. PubMed ID: 26739900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
    Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
    Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strategy for molecular testing in pulmonary carcinoma].
    Penault-Llorca F; Tixier L; Perrot L; Cayre A
    Ann Pathol; 2016 Jan; 36(1):73-9. PubMed ID: 26778816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
    Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
    Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma in serous effusions: Avoiding pitfalls in this rare encounter.
    LePhong C; Hubbard EW; Van Meter S; Nodit L
    Diagn Cytopathol; 2017 Dec; 45(12):1095-1099. PubMed ID: 29024544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.
    Yang Z; Tian H; Li L; Li C; Xu J; Bie F; Chen Y; Tian Y; Bai G; Peng Y; Yang J; Fan T; Xiao C; Liu W; Liu L; Li R; Sun S; Zheng B; Tan F; Ying J; Li C; Gao S; He J
    Int J Cancer; 2022 Sep; 151(5):717-729. PubMed ID: 35612583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of ΔNp63 expression in lung non-small cell carcinomas.
    Nonaka D
    Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Resected Non-Small Cell Lung Carcinomas: A Comparative Study With Morphology and Traditional Immunohistochemistry.
    HooKim K; Chaudoir CS; Chaudhery SI; Reid MD
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):27-34. PubMed ID: 27258567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reclassifying bronchial-pulmonary carcinoma: differentiating histological type in biopsies by immunohistochemistry.
    Carvalho L
    Rev Port Pneumol; 2009; 15(6):1101-19. PubMed ID: 19859629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.
    Pelosi G; Barbareschi M; Cavazza A; Graziano P; Rossi G; Papotti M
    Lung Cancer; 2015 Mar; 87(3):226-31. PubMed ID: 25620799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification.
    Weissferdt A; Kalhor N; Correa AM; Moran CA
    Hum Pathol; 2017 May; 63():14-26. PubMed ID: 27993578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
    Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
    Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.